Work

A letter to the editor in response to: indirect comparison of the relative vaccine effectiveness of mRNA-1283 vs. BNT162b2 vaccines against symptomatic COVID-19 among US adults

Year: 2025

Type: letter

Abstract: Dear Editor:We have identified several issues in the Moderna-funded indirect treatment comparison (ITC) by Beck et al. comparing vaccine effectiveness (VE) of mRNA-1283 and BNT162b2 COVID-19 vaccin...

Source: Current Medical Research and Opinion

DOI: 10.1080/03007995.2025.2502123

Authors: Hannah R. Volkman, Santiago M. C. Lopez, Mary M. Moran, Haitao Chu, Joseph C. Cappelleri, Jennifer L. Nguyen, John M. McLaughlin, Alejandro D. Cane

Institution: Pfizer (United States)

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4410122011

Cites: 35

Cited by: 1

Related to: 10